IDEX (NYSE:IEX) Releases Earnings Results

IDEX (NYSE:IEX) released its quarterly earnings data on Wednesday. The industrial products company reported $2.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.04 by $0.06, FiscalAI reports. The business had revenue of $899.10 million during the quarter, compared to analysts’ expectations of $882.00 million. IDEX had a net margin of 13.97% and a return on equity of 15.20%. The company’s revenue for the quarter was up 4.2% on a year-over-year basis. During the same period in the previous year, the company earned $2.04 EPS. IDEX updated its Q1 2026 guidance to 1.730-1.780 EPS and its FY 2026 guidance to 8.150-8.35 EPS.

Here are the key takeaways from IDEX’s conference call:

• IDEX’s Health & Science Technologies (HST) segment showed strong momentum with 34% organic orders growth in Q4, ~$493M in segment orders and broad demand in data-center, semiconductor, space/defense and related applications, giving management higher conviction for HST into 2026.
• The company reported better-than-expected Q4 results with adjusted EBITDA margin +40 bps, an adjusted EPS beat, and strong cash generation — $617M free cash flow for FY‑2025 (103% conversion), ~$1.1B liquidity and ~$250M of share repurchases in 2025.
• 2026 guidance is modestly paced: organic growth 1%–2%, adjusted EBITDA margin targeted at 26.5%–27% and adjusted EPS of $8.15–$8.35, reflecting mid-single-digit HST growth offset by flat-to-down FMT and FSDP.
• Industrial-facing segments remain soft — FMT saw only +4% orders/+1% sales and FSDP had flat orders and -5% sales, with ongoing weakness in chemicals, energy, agriculture and international fire & safety demand and no clear macro inflection yet.
• Capital allocation remains shareholder-friendly and disciplined: focus on tuck‑in M&A (integrating Micro‑LAM), maintaining investment‑grade leverage, a dividend target of 30%–35% of adjusted net income, and a base repurchase cadence (~$75M/quarter assumption).

IDEX Price Performance

NYSE IEX traded up $6.84 during mid-day trading on Wednesday, hitting $208.45. The stock had a trading volume of 469,171 shares, compared to its average volume of 735,408. The company has a 50 day simple moving average of $184.24 and a 200 day simple moving average of $172.50. The company has a quick ratio of 2.06, a current ratio of 2.93 and a debt-to-equity ratio of 0.47. The company has a market cap of $15.60 billion, a price-to-earnings ratio of 33.01, a P/E/G ratio of 1.99 and a beta of 1.00. IDEX has a 52-week low of $153.36 and a 52-week high of $209.55.

IDEX Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, January 30th. Stockholders of record on Friday, January 16th were paid a dividend of $0.71 per share. The ex-dividend date of this dividend was Friday, January 16th. This represents a $2.84 annualized dividend and a dividend yield of 1.4%. IDEX’s payout ratio is 44.94%.

More IDEX News

Here are the key news stories impacting IDEX this week:

• Positive Sentiment: IDEX beat both top‑line and bottom‑line estimates for Q4 — $2.10 EPS vs. consensus ~ $2.04 and revenue of $899.1M (up ~4.2% YoY) with healthy margins and ROE — signaling continued operational strength. Article Title
• Positive Sentiment: Management released a slide deck and press release alongside results, providing detail on drivers behind the beat (useful for investors assessing sustainability of growth). Press Release / Slides
• Neutral Sentiment: Analysts and outlets are processing the quarter and guidance; some coverage highlights the company’s strong business fundamentals but flags valuation as a consideration. Article Title
• Negative Sentiment: IDEX set Q1 FY26 EPS guidance at $1.73–1.78 (consensus ~ $1.84) and FY26 EPS at $8.15–8.35 (consensus ~ $8.31) — ranges that are modestly below analysts’ expectations and could cap near‑term upside. Article Title

Analysts Set New Price Targets

IEX has been the subject of several research analyst reports. Oppenheimer set a $210.00 target price on shares of IDEX in a report on Tuesday, October 7th. Stifel Nicolaus boosted their target price on IDEX from $200.00 to $220.00 and gave the company a “buy” rating in a report on Friday, January 23rd. TD Cowen reissued a “buy” rating on shares of IDEX in a report on Wednesday, December 3rd. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of IDEX in a report on Wednesday, October 8th. Finally, Citigroup increased their price target on shares of IDEX from $197.00 to $202.00 and gave the stock a “buy” rating in a research note on Monday, December 8th. Five investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $203.29.

Hedge Funds Weigh In On IDEX

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Two Sigma Investments LP raised its position in shares of IDEX by 446.8% during the 3rd quarter. Two Sigma Investments LP now owns 329,337 shares of the industrial products company’s stock worth $53,603,000 after purchasing an additional 269,109 shares during the last quarter. Invesco Ltd. lifted its position in shares of IDEX by 16.1% in the third quarter. Invesco Ltd. now owns 1,809,788 shares of the industrial products company’s stock valued at $294,561,000 after acquiring an additional 250,447 shares in the last quarter. Amundi increased its position in IDEX by 18.7% during the 3rd quarter. Amundi now owns 1,517,903 shares of the industrial products company’s stock worth $248,751,000 after purchasing an additional 239,215 shares in the last quarter. Squarepoint Ops LLC increased its stake in IDEX by 635.4% in the second quarter. Squarepoint Ops LLC now owns 264,492 shares of the industrial products company’s stock valued at $46,437,000 after purchasing an additional 228,525 shares during the last quarter. Finally, Voloridge Investment Management LLC grew its holdings in IDEX by 82.4% in the 3rd quarter. Voloridge Investment Management LLC now owns 422,936 shares of the industrial products company’s stock valued at $68,837,000 after buying an additional 191,014 shares during the period. Institutional investors and hedge funds own 97.96% of the company’s stock.

IDEX Company Profile

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.